Santarus Clinical Investigational Site 5032 — Tampa, Florida

Santarus Clinical Investigational Site 5032 is a clinical research site located in Tampa, Florida, United States 33607.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Santarus Clinical Investigational Site 5032 has participated in 2 clinical trials.

Therapeutic areas: Ulcerative Colitis.

Sponsors: Bausch Health Americas, Inc..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Santarus Clinical Investigational Site 5032?

Santarus Clinical Investigational Site 5032 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Santarus Clinical Investigational Site 5032 conducted?

Santarus Clinical Investigational Site 5032 has 2 clinical trials on record. Their work covers Ulcerative Colitis.

Is Santarus Clinical Investigational Site 5032 accredited by Crixeo Health?

Santarus Clinical Investigational Site 5032 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Santarus Clinical Investigational Site 5032?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.